Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Download Screening For Asymptomatic Carotid Artery Stenosis full books in PDF, epub, and Kindle. Read online Screening For Asymptomatic Carotid Artery Stenosis ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Download or read book Screening For Asymptomatic Carotid Artery Stenosis written by and published by . This book was released on 2007 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Author : U. S. Department Human Services
Publisher :
ISBN 13 : 9781490902173
Total Pages : 44 pages
Book Rating : 4.9/5 (21 download)
Download or read book Screening for Asymptomatic Carotid Artery Stenosis written by U. S. Department Human Services and published by . This book was released on 2013-07-02 with total page 44 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cerebrovascular disease is the third leading cause of death in the U.S. Approximately 500,000 Americans each year suffer a first stroke. The mortality rate for cerebrovascular disease has declined by nearly 70% since 1950. Much of the decrease is likely due to reduced cigarette smoking and improved control of hypertension. In addition to controlling such risk factors as tobacco use and hypertension, carotid endarterectomy (CEA) has been proposed as a strategy for reducing the burden of suffering due to stroke. Randomized controlled trials (RCTs) have shown that CEA effectively reduces stroke among people who have severe carotid artery stenosis (CAS) and have had a transient ischemic attack (TIA) or "minor stroke." It is not clear, however, whether screening asymptomatic people (i.e., those who have never had a TIA) to detect CAS and treatment with CEA is effective in reducing stroke. In 1996, the USPSTF concluded that there was insufficient evidence to recommend for or against screening of asymptomatic persons for CAS using physical exam or carotid ultrasound. This recommendation was based on new evidence at the time, including the Asymptomatic Carotid Artery Study (ACAS), a RCT involving 1662 subjects with asymptomatic stenosis greater than 60%. Results of ACAS suggested that the overall benefit of treatment with CEA depends greatly on the perioperative complications. At that time, there was limited information about CEA complications in the general population. After a trend of declining usage of CEA, the publication of ACAS led to a reversal and the number of carotid endarterectomies performed in the U.S. increased significantly. Data then began to emerge about complication rates from CEA performed in community and academic settings. Since the previous Task Force review, the largest RCT of CEA versus medical treatment of asymptomatic CAS, the Asymptomatic Carotid Surgery Trial (ACST), has been published. This review updates the 1996 Task Force review of screening for CAS, focusing on duplex ultrasound as the screening test (with various confirmation tests) and CEA as the treatment for clinically important CAS. It draws upon the 1996 recommendation, updates the evidence on the natural history of CAS, the accuracy of screening tests, and the benefits of treatment for CAS with CEA, and includes a systematic review of the evidence since 1994 on the harms of carotid endarterectomy. Medical interventions were not reviewed in this report. The USPSTF has reviewed screening for several identified CAS and stroke factors, including hyperlipidemia, hypertension, aspirin prophylaxis, and smoking. The key questions were: Key Question 1. Is there direct evidence that screening adults with ultrasound for asymptomatic CAS reduces fatal and/or nonfatal stroke? Key Question 2. What is the accuracy and reliability of ultrasound to detect clinically important CAS? Key Question 3. For people with asymptomatic CAS 60%-99%, does intervention with CEA reduce CAS-related morbidity or mortality? Key Question 4. Does treatment for asymptomatic CAS 60%-99% with CEA result in harm?
Author : Agency for Healthcare Research and Quality
Publisher : CreateSpace
ISBN 13 : 9781508439509
Total Pages : 166 pages
Book Rating : 4.4/5 (395 download)
Download or read book Screening for Asymptomatic Carotid Artery Stenosis written by Agency for Healthcare Research and Quality and published by CreateSpace. This book was released on 2015-02-11 with total page 166 pages. Available in PDF, EPUB and Kindle. Book excerpt: Carotid artery stenosis refers to atherosclerotic narrowing of the extracranial carotid arteries. It typically refers to the internal carotid arteries or the common and internal carotid arteries. A “clinically important” degree of stenosis is defined as the percentage of stenosis that corresponds to a substantially increased risk for stroke. However, because stroke risk depends on more than just the degree of stenosis, it is difficult to set a lower limit on the range that defines potential clinical importance. Asymptomatic patients have no significant neurologic symptoms referable to the carotid artery and have not experienced a cerebrovascular event (i.e., a stroke or transient ischemic attack). The main purpose of this report is to systematically evaluate the current evidence on whether screening asymptomatic adults for CAS reduces the risk for fatal or nonfatal ipsilateral stroke and the evidence on harms associated with screening and interventions for CAS. The scope and methods of this report differ from earlier USPSTF reviews on this topic by 1) using systematic methods for all key question, 2) addressing new key questions about the availability of valid, reliable risk stratification tools to distinguish a person's likelihood for asymptomatic CAS and to distinguish risk for ipsilateral stroke caused by CAS or for harms from surgery or intervention in persons with asymptomatic CAS (recommendations of some groups state that screening might be considered for persons with multiple risk factors), 3) adding carotid angioplasty and stenting (CAAS) to the included interventions, 4) adding a question about the incremental benefit of medical therapy for asymptomatic CAS, and 5) conducting quantitative synthesis for many outcomes.
Author : Tracy A. Wolff
Publisher :
ISBN 13 :
Total Pages : pages
Book Rating : 4.:/5 (864 download)
Download or read book Screening for Asymptomatic Carotid Artery Stenosis written by Tracy A. Wolff and published by . This book was released on 2007 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: BACKGROUND: Cerebrovascular disease is the third leading cause of death in the U.S. The proportion of all strokes attributable to previously asymptomatic carotid stenosis is low. In 1996, the United States Preventive Services Task Force concluded that there was insufficient evidence to recommend for or against screening of asymptomatic persons for CAS using physical exam or carotid ultrasound. PURPOSE: To examine the evidence of benefits and harms of screening asymptomatic patients with duplex ultrasound and treatment with carotid endarterectomy (CEA) for carotid artery stenosis (CAS). DATA SOURCES: MEDLINE and Cochrane Library searches (January 1994-April 2007), recent systematic reviews, reference lists of retrieved articles, and expert suggestions. STUDY SELECTION: English language studies were selected to answer the following: Is there direct evidence that screening with ultrasound for asymptomatic CAS reduces strokes? What is the accuracy of ultrasound to detect CAS? Does intervention with CEA reduce morbidity or mortality? Does screening or CEA result in harm? The following study types were selected: randomized controlled trials (RCT) of screening for CAS; RCTs of CEA versus medical treatment; systematic reviews of screening tests; observational studies of harms from CEA. DATA EXTRACTION: Studies were reviewed, abstracted, and rated for quality using predefined USPSTF criteria. DATA SYNTHESIS: There have been no RCTs of screening for CAS. According to systematic reviews, the sensitivity of ultrasound is approximately 94% and the specificity is approximately 92%. Treatment of CAS in selected patients with selected surgeons could lead to an approximately 5% absolute reduction in strokes over 5 years. Thirty-day stroke and death rates from CEA vary from 2.7% to 4.7% in RCTs; higher rates have been reported in observational studies (up to 6.7%). LIMITATIONS: There is inadequate evidence to stratify people into categories of risk for clinically important CAS. The RCTs of CEA versus medical treatment were conducted in selected populations with selected surgeons. CONCLUSIONS: The actual stroke reduction from screening asymptomatic patients and treatment with CEA is unknown; the benefit is limited by a low overall prevalence of treatable disease in the general asymptomatic population and harms from treatment.
Author : Janelle Guirguis-Blake
Publisher :
ISBN 13 :
Total Pages : 93 pages
Book Rating : 4.:/5 (128 download)
Download or read book Screening for Asymptomatic Carotid Artery Stenosis in the General Population written by Janelle Guirguis-Blake and published by . This book was released on 2021 with total page 93 pages. Available in PDF, EPUB and Kindle. Book excerpt: OBJECTIVE: To perform a targeted systematic review of evidence regarding the benefits and harms of screening for asymptomatic carotid artery stenosis in the general population to support the update of the USPSTF's 2014 D recommendation for this topic. DATA SOURCES: We conducted a literature search of MEDLINE, PubMed Publisher-Supplied Records, and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1, 2014, to February 14, 2020. In addition, we conducted ongoing surveillance of relevant literature through November 20, 2020. STUDY SELECTION: We screened 2,374 abstracts and 144 full-text articles against a priori inclusion criteria. Retrospective analyses of vascular surgical registries were limited to data collected in the United States. DATA ANALYSIS: Working independently, two investigators critically appraised each article that met inclusion criteria using design-specific criteria. We abstracted and narratively synthesized data from included studies. The results discussed in this report are limited to studies published since the previous review to support the 2014 recommendation. RESULTS: No eligible studies were identified that directly examined the benefits or harms of screening for asymptomatic carotid artery stenosis. Since the last USPSTF recommendation on this topic, two limited, fair-quality, prematurely terminated trials reported mixed results for the comparative effectiveness of carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus best medical treatment (BMT) compared with BMT alone. The SPACE-2 trial (N=316 reported no difference in composite outcome of stroke or death (30 days) or ipsilateral ischemic stroke (1 year) after CEA (unadjusted hazard ratio [HR] 2.82 [95% CI, 0.33 to 24.07]) or CAS (unadjusted HR 3.50 [95% CI, 0.42, 29.11]) compared with BMT in the 1-year interim publication. The smaller AMTEC trial (N=55) reported a statistically significantly lower composite risk of nonfatal ipsilateral stroke or death among the carotid endarterectomy (CEA) arm at 3.3 median years of followup (calculated unadjusted HR 0.20 [95% CI, 0.06 to 0.65]). Since the previous report, two fair-quality trials, two national datasets, and three surgical registries met our inclusion criteria reporting harms associated with CEA (N=1,903,761) or carotid artery stenting (CAS) (N=332,103). Overall, the rates of most postoperative adverse events were highest among analyses of national databases (Medicare data and National Inpatient Sample [NIS]), with lower rates reported in trials and surgical registries. Within the national databases and surgical registries, rates of 30-day postoperative stroke or death following CEA ranged from as low as 1.4 percent in the Vascular Quality Initiative (VQI) to as high as 3.5 percent in the Medicare database. Thirty-day postoperative mortality ranged from 0.5 percent in the Vascular Study Group of New England (VSGNE) to as high as 1.1 percent in the Medicare database for CEA. Thirty-day postoperative stroke rates following CEA ranged from 0.5 percent in the VSGNE to 1.5 percent in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). For the CAS procedure, 30-day stroke or death ranged from 2.6 percent in the VQI to 5.1 percent in Medicare. Thirty-day postoperative mortality after CAS ranged from 1.1 percent in the VQI to 3.1 percent in the Medicare database. Thirty-day postoperative stroke rates following CAS were only reported in the VQI at 1.8 percent. Rates of postoperative harms within the trials were generally underpowered to detect outcomes such as postoperative mortality. Within the SPACE-2 trial, the composite of 30-day postoperative stroke or death was reported at 2.5 percent following both CAS and CEA. Perioperative stroke was reported in one patient (3.2%) following CEA in the AMTEC trial. The other most common harms reported within trials included hematoma, facial nerve lesion, and contrast agent incompatibility. LIMITATIONS: We identified no trials of screening versus no screening in unselected general populations or examining direct screening harms. There were few new trials, all with methodologic concerns, examining the important question of the comparative effectiveness and harms of revascularization plus best medical treatment compared with best medical treatment alone. Selection bias and measurement bias presented serious validity concerns for complication rates reported in the administrative databases and surgical registries. The procedural complication rates of patients categorized as "asymptomatic" in the harms studies may not be generalizable to the rates that may be expected in a population of screen-detected patients (who would be expected to have lower complication rates compared with populations with any neurologic symptoms or remote history of TIA or stroke) or procedures performed outside of trials by less-selected operators (who may be expected to have higher complication rates compared with highly selected operators at high volume centers). CONCLUSIONS: There are no population-based screening trials addressing the benefits and harms of screening for carotid artery stenosis. Limited new evidence has emerged to determine the benefits of carotid revascularization over contemporary best medical management in asymptomatic patients. The ongoing CREST-2 and ECST-2 trials will be the largest trials to address this issue. Large national administrative databases and surgery registries suggest that postoperative 30-day stroke/death rates vary widely--1.4 to 3.5 percent for CEA and 2.6 to 5.1 percent for CAS--suggesting that there may be a wide variation in complication rates likely attributable to patient and operator selection.
Author : Issam D. Moussa
Publisher : CRC Press
ISBN 13 : 0203089855
Total Pages : 240 pages
Book Rating : 4.2/5 (3 download)
Download or read book Asymptomatic Carotid Artery Stenosis written by Issam D. Moussa and published by CRC Press. This book was released on 2007-03-06 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: This well-illustrated text reviews the current state of knowledge with regard to the various anatomic and physiologic methods available to identify asymptomatic patients who are at high risk to develop a future stroke. Asymptomatic Carotid Artery Stenosis is particularly targeted towards physicians involved in clinical decision making regarding rev
Author : Dan Jonas
Publisher :
ISBN 13 :
Total Pages : 159 pages
Book Rating : 4.:/5 (897 download)
Download or read book Screening for Asymptomatic Carotid Artery Stenosis written by Dan Jonas and published by . This book was released on 2014 with total page 159 pages. Available in PDF, EPUB and Kindle. Book excerpt: PURPOSE: To evaluate the evidence on screening and treating asymptomatic adults for carotid artery stenosis (CAS) for the U.S. Preventive Services Task Force (USPSTF). DATA SOURCES: PubMed/MEDLINE, the Cochrane Library, EMBASE, and trial registries through September 2013; reference lists of published literature; MEDLINE searches for trials were updated through March 2014. STUDY SELECTION: Two investigators independently selected studies reporting on asymptomatic adults with CAS, including randomized, controlled trials (RCTs) of screening for CAS; RCTs of carotid endarterectomy (CEA) or carotid angioplasty and stenting (CAAS) versus medical treatment; RCTs of medications versus placebo added to current standard medical therapy; multi-institution trials or cohort studies reporting harms; relevant systematic reviews; and studies that attempted to externally validate risk stratification tools. DATA EXTRACTION: One reviewer extracted data and a second checked accuracy. Two independent reviewers assigned quality ratings using predefined criteria. DATA SYNTHESIS: No RCTs compared screening with no screening, CAAS with medical treatment, or assessed intensification of medical therapy. Given the specificity of ultrasound (range 88% to 94% for CAS e50% to e70%), its use in low-prevalence populations would yield many false-positive results. Only one fair-quality study attempted external validation of a risk stratification tool to distinguish persons who are more likely to have CAS; the tool's discrimination was inadequate (c-statistic for e50% CAS, 0.60; 95% CI, 0.56 to 0.64). Our meta-analyses of RCTs comparing CEA with medical therapy found an absolute risk reduction of 5.5 percent (95% CI, 3.9 to 7.0) for any nonperioperative stroke over approximately 5 years. Meta-analyses for perioperative (30-day) stroke or death after CEA found rates of 2.4 percent (95% CI, 1.7 to 3.1) using all trials of CEA, regardless of the comparator; and 3.3 percent (95% CI, 2.7 to 3.9) using cohort studies (7 studies; n=17,474). Rates of perioperative stoke or death after CAAS were similar or slightly higher. Other important potential harms of CEA or CAAS include nonfatal perioperative myocardial infarction (approximately 0.8% rate after CEA), cranial nerve injury, pulmonary embolism, pneumonia, local hematoma requiring surgery, and psychological harms (e.g., anxiety or labeling). Externally validated, reliable risk stratification tools that can distinguish persons with asymptomatic CAS who have increased or decreased risk for ipsilateral stroke or harms after CEA or CAAS are not available. LIMITATIONS: Medical therapy in trials varied and often lacked treatments that are now standard. For this reason, and because advances in medical therapy have reduced the rate of stroke in persons with asymptomatic CAS in recent decades, the true reduction of stroke or composite reduction of cardiovascular events is unknown. Trials utilized highly selected surgeons. No trials focused on a population identified by screening in primary care. Harms may be underreported. CONCLUSION: Current evidence does not sufficiently establish incremental overall benefit of CEA, CAAS, or intensification of medical therapy beyond current standard medical therapy. Potential for overall benefit is limited by low prevalence in the general asymptomatic population and by harms from screening and treatment. Evidence is insufficient to allow reliable risk stratification.
Author : Peter Schneider
Publisher : CRC Press
ISBN 13 : 1000611388
Total Pages : 346 pages
Book Rating : 4.0/5 (6 download)
Download or read book Carotid Interventions written by Peter Schneider and published by CRC Press. This book was released on 2004-08-30 with total page 346 pages. Available in PDF, EPUB and Kindle. Book excerpt: From patient selection and monitoring to follow-up care, Carotid Interventions is the first source to offer a practical how-to approach to carotid angioplasty and stenting-providing maneuvers and strategies for difficult situations, as well as step-by-step guidance on specific surgical procedures, equipment selection and instrumentation, protection
Author : Gowri Raman
Publisher :
ISBN 13 :
Total Pages : pages
Book Rating : 4.:/5 (91 download)
Download or read book Management of Asymptomatic Carotid Stenosis written by Gowri Raman and published by . This book was released on 2012 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Stroke is a leading cause of death in the United States. Although the number of deaths from stroke has declined in recent years, it continues to be a major public health problem in the United States, with an estimated $34.3 billion in direct cost and indirect cost of stroke in the year 2008. Carotid artery stenosis represents an important risk factor for ischemic stroke, which accounts for nearly 90 percent of all strokes among U.S. men and women. Carotid artery stenosis is increasingly prevalent from the fifth decade of life onward. Patients with vascular disease and multiple risk factors (e.g., diabetes, hypertension, hyperlipidemia, and smoking) have a higher probability of having asymptomatic carotid stenosis. Since carotid artery atherosclerosis can largely proceed silently and unpredictably, the first manifestation can be a debilitating or fatal stroke. Asymptomatic carotid artery stenosis affects approximately 7 percent of women and over 12 percent of men, older than 70 years of age. Clinically important stenosis, at which the risk of stroke is increased, is defined as stenosis of over 50 or 60 percent. Natural history studies have reported that patients with asymptomatic carotid stenosis are at an increased risk of ipsilateral carotid territory ischemic stroke ranging from 5 to 17 percent. The goal of management of asymptomatic carotid stenosis is to decrease the risk of stroke and stroke-related deaths. However, screening asymptomatic patients for carotid stenosis is not part of common clinical practice as noted in a review by the U.S. Preventive Services Task Force from 1996, which concluded that evidence was insufficient to recommend either for or against screening. As the general U.S. population ages, and with the availability of noninvasive imaging studies, asymptomatic carotid artery stenosis may be more frequently detected in the course of patient management. Auscultation of the carotid arteries to listen for bruits is by convention an initial means of clinical assessment of high-risk patients, but the presence of bruits is not necessarily indicative of significant stenosis. Since carotid auscultation has limited sensitivity in detecting significant carotid stenosis, additional imaging modalities including digital subtraction angiography (DSA), Doppler ultrasound (DUS), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) are being increasingly utilized. The most commonly used measurement method of carotid stenosis used in clinical trials or most common angiographic method was introduced in the North American Symptomatic Carotid Endarterectomy Trial (NASCET). In the NASCET method, the stenosis is measured as the ratio of the linear luminal diameter of the narrowest portion of the artery's diseased segment divided by the diameter of the healthy distal carotid artery (above the post-stenotic dilation). An alternative method was used in the European Carotid Surgery Trial (ECST), which utilized the estimated carotid bulb at the site of maximal stenosis as the denominator. The ECST method tends to yield higher degrees of stenosis, but measurements made by each method can be converted to those of the other using a simple arithmetic equation. According to the 2003 Society of Radiologists in Ultrasound consensus criteria, a carotid stenosis is not quantified as an exact percentage of luminal stenosis but can be classified by range of stenoses that represent clinically relevant categories (normal,
Author : Ali F. AbuRahma
Publisher : Springer
ISBN 13 : 3319547607
Total Pages : 853 pages
Book Rating : 4.3/5 (195 download)
Download or read book Noninvasive Vascular Diagnosis written by Ali F. AbuRahma and published by Springer. This book was released on 2017-10-02 with total page 853 pages. Available in PDF, EPUB and Kindle. Book excerpt: This large format book is the definitive text on vascular surgery written by expert editors and contributors. It is well supported by exceptional illustrative material. The book is invaluable to all those who work in vascular laboratories as wel.l as internists, cardiologists, vascular laboratory directors and staff, general surgeons involved in vascular surgery and the vascular surgery community in general Noninvasive Vascular Diagnosis comprehensively covers all aspects of noninvasive evaluation of the circulatory system in the extremities. The increasing popularity of noninvasive techniques is not reflected in the number of comprehensive works on the topic and it is clear from the success of the first edition that the demand for an updated volume is increasing.
Author : M. de Weerd
Publisher :
ISBN 13 :
Total Pages : pages
Book Rating : 4.:/5 (847 download)
Download or read book Asymptomatic carotid arterial stenosis - population based screening written by M. de Weerd and published by . This book was released on 2010 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Author : Morteza Naghavi
Publisher : Springer Science & Business Media
ISBN 13 : 1603271791
Total Pages : 712 pages
Book Rating : 4.6/5 (32 download)
Download or read book Asymptomatic Atherosclerosis written by Morteza Naghavi and published by Springer Science & Business Media. This book was released on 2010-07-01 with total page 712 pages. Available in PDF, EPUB and Kindle. Book excerpt: Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors introduce a comprehensive approach to identifying the vulnerable patients (asymptomatic individuals at risk of a near future adverse event). Additional chapters discuss future directions towards containing the epidemic of atherosclerotic cardiovascular disease using innovative solutions such as preemptive interventional therapies (bioabsorbable stents) for stabilization of vulnerable atherosclerotic plaques, mass unconditional Polypill therapy for population-based risk reduction, and ultimately vaccination strategies to prevent the development of atherosclerosis. Up-to-date and authoritative, Asymptomatic Atherosclerosis: Pathophysiology, Detection, and Treatment is a must-have for any cardiologist or primary care physician who wishes to practice modern preventive cardiology and manage the increasing number of asymptomatic atherosclerotic patients. Outlines more accurate measures of risk (coronary artery calcium and carotid intima-media thickness) than traditional risk factors (total cholesterol, LDL cholesterol, HDL cholesterol) Presents new multipronged strategies to aid in the early detection and treatment of high risk asymptomatic patients
Author : László Csiba
Publisher : Cambridge University Press
ISBN 13 : 1107659159
Total Pages : 333 pages
Book Rating : 4.1/5 (76 download)
Download or read book Manual of Neurosonology written by László Csiba and published by Cambridge University Press. This book was released on 2016-04-28 with total page 333 pages. Available in PDF, EPUB and Kindle. Book excerpt: Neurosonology is non-invasive, portable, and has excellent temporal resolution, making it a valuable and increasingly popular tool for the diagnosis and monitoring of neurological conditions when compared to other imaging techniques. This guide looks beyond the use of neurovascular ultrasound in stroke to encompass a wide range of other neurological diseases and emergencies. It offers a practical approach to the examination of patients, interpretation of ultrasound studies, and the application of neurosonology to the development of management and treatment strategies. Each chapter incorporates a thorough and clear procedural methodology alongside scanning tips for trainees; this step-by-step approach is further enhanced by example images and focused diagnostic questions. Authored and edited by international experts, this practical manual of neurosonology is an invaluable resource for neurologists, neurosurgeons, intensivists, radiologists, and ultrasonographers.
Author : Michael Brainin
Publisher : Cambridge University Press
ISBN 13 : 1107047498
Total Pages : 425 pages
Book Rating : 4.1/5 (7 download)
Download or read book Textbook of Stroke Medicine written by Michael Brainin and published by Cambridge University Press. This book was released on 2014-09-11 with total page 425 pages. Available in PDF, EPUB and Kindle. Book excerpt: Fully revised throughout, the new edition of this concise textbook is aimed at doctors preparing to specialize in stroke care.
Author : Mark K. Eskandari
Publisher : PMPH-USA
ISBN 13 : 9781607950523
Total Pages : 368 pages
Book Rating : 4.9/5 (55 download)
Download or read book Carotid Artery Disease written by Mark K. Eskandari and published by PMPH-USA. This book was released on 2010 with total page 368 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Compilation of presentations on topics relating to carotid artery disease from the last five symposia sponsored by the Division of Vascular Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA"--Pref.
Author : Michel Henry
Publisher : John Wiley & Sons
ISBN 13 : 1444329820
Total Pages : 929 pages
Book Rating : 4.4/5 (443 download)
Download or read book The Carotid and Supra-Aortic Trunks written by Michel Henry and published by John Wiley & Sons. This book was released on 2011-02-25 with total page 929 pages. Available in PDF, EPUB and Kindle. Book excerpt: Carotid Angioplasty and Stenting (CAS) is a new approach to treat a carotid stenosis. This new book provides interventional cardiologists, both as beginners or fully experienced, with a reference on all aspects of angioplasty and stenting of the carotid and supra-aortic trunks. Focusing on both the entire range of angioplasty and stenting treatment options for the surgeon treating patients on the operating table, and the range of radiological techniques used for the cardiologist to diagnose carotid artery stenosis (CAS) and associated conditions, this important book describes the best indications, the different techniques, the results, and also the limitations of CAS based on randomized studies and particularly the last published data (CREST study). Suitable for both novice and experienced interventionalists, it also addresses diagnosis of a carotid stenosis and complications from CAS and how to manage them.
Author : Mark Creager
Publisher : Elsevier Health Sciences
ISBN 13 : 0323636012
Total Pages : 963 pages
Book Rating : 4.3/5 (236 download)
Download or read book Vascular Medicine: A Companion to Braunwald's Heart Disease E-Book written by Mark Creager and published by Elsevier Health Sciences. This book was released on 2019-05-22 with total page 963 pages. Available in PDF, EPUB and Kindle. Book excerpt: With authoritative coverage of everything from recent discoveries in the field of vascular biology to recent clinical trials and evidence-based treatment strategies, Vascular Medicine, 3rd Edition, is your go-to resource for improving your patients' cardiovascular health. Part of the Braunwald family of renowned cardiology references, this updated volume integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular diseases, making it an ideal reference for vascular medicine specialists, general cardiologists, interventional cardiologists, vascular surgeons, and interventional radiologists. - Incorporates technologic advances in vascular imaging – including ultrasound, MRI, CTA, and catheter-based angiography – along with more than 230 new figures, providing an up-to-date and complete view of the vascular system and vascular diseases. - Covers novel antithrombotic therapies for peripheral artery disease and venous thromboemboism, advances in endovascular interventions for aortic aneurysms, and today's best surgical treatments for vascular diseases. - Includes seven new chapters: Pathobiology of Aortic Aneurysms; Pathobiology and Assessment of Cardiovascular Fibrosis; Large Vessel Vasculitis; Medium and Small Vessel Vasculitis; Epidemiology and Prognosis of Venous Thromboembolic Disease; Fibromuscular Dysplasia; and Dermatologic Manifestations of Vascular Disease. - Discusses methods for aggressive patient management and disease prevention to ensure minimal risk of further cardiovascular problems. - Keeps you current with ACC/AHA and ECC guidelines and the best ways to implement them in clinical practice. - Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices
